The testicles have been diagnosed with stage III testicular cancer, which has spread to lymph nodes and organs outside of the testicles. Metastasized testicular cancer is another name for this stage of malignancy. Patients with stage III testicular cancer have excessively high levels of tumour markers.

Testicular cancer is classified into three phases at stage III:

Stage IIIA: The cancer has spread beyond the lymph nodes and testicles in this stage. The amount of the tumour marker protein is somewhat greater than normal.

Stage IIIB : The testicular cancer is identified by moderately greater levels of tumour marker proteins. The cancer has metastasized at this point, which implies it has spread to surrounding and distant nodes, as well as the lungs.

Stage IIIC: This stage of testicular cancer is often known as stage 4 of the disease. The cancer has migrated to other distant organs and is strongly metastasized here. The levels of tumour markers in the blood can be extremely high.


Treatment for stage III testicular cancer is determined by whether the tumour is seminoma or non-seminoma, while other factors such as the patient's medical history and tolerance also play a role.

Testicular cancer in stage III cannot be effectively treated with a single treatment. Surgical treatments, along with other treatments, are used to resect tumours and limit the proliferation of cancer cells in the body.


  • Surgery to resect tumours, followed by chemotherapy in combination, is the treatment for stage III seminomas.
  • Surveillance for the presence or absence of tumours is performed if the malignancy has not been totally cured. If tumours are found after two months of treatment, a PET scan is performed to eliminate them.
  • Chemotherapy trial in the clinic.


  • Surgical treatments to remove the tumours, followed by chemotherapy to destroy any remaining testicular cancer cells in the body, are used to treat stage III nonseminomas.
  • Chemotherapy is used first, followed by surgery. If the cancer is still not entirely treated after surgery, a second dosage of chemotherapy may be required, depending on the findings of the follow-up tests.
  • If the testicular cancer is in a highly advanced stage, it may be treated with a combination of chemotherapy before surgery.


The 5-year survival rate is the percentage of patients who have lived 5 years after being diagnosed for every 100 patients diagnosed.

Stage III testicular cancer is a malignancy that has spread widely. It has an 80 percent intermediate survival rate, which indicates that 80 out of every 100 men diagnosed with stage III testicular cancer survive.

Stage IIIC testicular cancer has a low survival rate of 70-80% when compared to other stages of testicular cancer. This is due to the fact that cancer that has migrated to other organs might also cause difficulties in those organs.

The cancer survival rate is entirely dependent on the sort of treatment given to patients, as well as other factors